{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-033047","form_type":"8-K","ticker":"SLE","cik":"0001621672","company_name":"Super League Enterprise, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.949278+00:00","generated_at":"2026-05-17T00:38:16.328559+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Super League regains Nasdaq compliance; delisting hearing cancelled","bullets":["Nasdaq notified Super League on Oct 28, 2025 of regained compliance with Rule 5550(b).","Company now in compliance with all continued listing requirements.","Scheduled November 11, 2025 hearing before Hearings Panel has been cancelled.","SLE common shares continue to trade uninterrupted on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-033047","json":"https://secwatch.observer/filing/0001437749-25-033047.json","markdown":"https://secwatch.observer/filing/0001437749-25-033047.md","text":"https://secwatch.observer/filing/0001437749-25-033047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925033047/0001437749-25-033047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621672/000143774925033047/slgg20251104_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:38:16.328559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001178913-26-002988","ticker":"SLXN","company_name":"Silexion Therapeutics Corp","filed_at":"2026-05-29T11:00:25+00:00","headline":"Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted","event_type":"regulatory","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-002988","json":"https://secwatch.observer/filing/0001178913-26-002988.json","markdown":"https://secwatch.observer/filing/0001178913-26-002988.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/0001178913-26-002988-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/zk2635442.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-062172","ticker":"RR","company_name":"RICHTECH ROBOTICS INC.","filed_at":"2026-05-28T20:49:32+00:00","headline":"Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing","event_type":"regulatory","sec_items":["3.01","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062172","json":"https://secwatch.observer/filing/0001213900-26-062172.json","markdown":"https://secwatch.observer/filing/0001213900-26-062172.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1963685/000121390026062172/0001213900-26-062172-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1963685/000121390026062172/ea0292546-8k_richtech.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-240645","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-05-27T13:10:06+00:00","headline":"Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027","event_type":"regulatory","sec_items":["7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-240645","json":"https://secwatch.observer/filing/0001193125-26-240645.json","markdown":"https://secwatch.observer/filing/0001193125-26-240645.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526240645/0001193125-26-240645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526240645/d129501d8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-025171","ticker":"MBOT","company_name":"Microbot Medical Inc.","filed_at":"2026-05-26T12:30:22+00:00","headline":"Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.","event_type":"regulatory","sec_items":["7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025171","json":"https://secwatch.observer/filing/0001493152-26-025171.json","markdown":"https://secwatch.observer/filing/0001493152-26-025171.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/0001493152-26-025171-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-060667","ticker":"LRHC","company_name":"La Rosa Holdings Corp.","filed_at":"2026-05-22T21:20:15+00:00","headline":"La Rosa Holdings receives Nasdaq deficiency notice for late 10-K and 10-Q filings","event_type":"regulatory","sec_items":["3.01","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-060667","json":"https://secwatch.observer/filing/0001213900-26-060667.json","markdown":"https://secwatch.observer/filing/0001213900-26-060667.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1879403/000121390026060667/0001213900-26-060667-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1879403/000121390026060667/ea0291964-8k_larosa.htm"},"side_by_side_evidence":null},{"accession":"0001731122-26-000781","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-05-22T12:15:26+00:00","headline":"Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026","event_type":"regulatory","sec_items":["3.01","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000781","json":"https://secwatch.observer/filing/0001731122-26-000781.json","markdown":"https://secwatch.observer/filing/0001731122-26-000781.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/0001731122-26-000781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/e7667_8-k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-065180","ticker":"ADGM","company_name":"Adagio Medical Holdings, Inc.","filed_at":"2026-05-21T20:31:34+00:00","headline":"Adagio submits PMA to FDA for vCLAS VT ablation system; trial shows 97.4% acute success","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-065180","json":"https://secwatch.observer/filing/0001104659-26-065180.json","markdown":"https://secwatch.observer/filing/0001104659-26-065180.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2006986/000110465926065180/0001104659-26-065180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2006986/000110465926065180/tm2614299d2_8k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-064863","ticker":"CGTX","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2026-05-21T11:34:37+00:00","headline":"Cognition Therapeutics completes productive FDA meeting for zervimesine in DLB psychosis","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-064863","json":"https://secwatch.observer/filing/0001104659-26-064863.json","markdown":"https://secwatch.observer/filing/0001104659-26-064863.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926064863/0001104659-26-064863-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926064863/tm2615260d1_8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}